Arthur Przybyl's Net Worth
$41 Million
Estimate Recalculated Nov 1, 2024 03:49AM EST
Who is Arthur Przybyl?
Arthur Przybyl has an estimated net worth of $41 Million. This is based on reported shares across multiple companies, which include AKORN INC, and BIOSANTE PHARMACEUTICALS INC.
SEC CIK
Arthur Przybyl's CIK is 0001268135
Past Insider Trading and Trends
2013 was Arthur Przybyl's most active year for acquiring shares with 19 total transactions. Arthur Przybyl's most active month to acquire stocks was the month of November. 2013 was Arthur Przybyl's most active year for disposing of shares, totalling 18 transactions. Arthur Przybyl's most active month to dispose stocks was the month of February. 2004 saw Arthur Przybyl paying a total of $1,500,036.00 for 750,081 shares, this is the most they've acquired in one year. In 2015 Arthur Przybyl cashed out on 92,789 shares for a total of $4,803,003.90, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AKORN INC No price found
President, CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$2.21 | -$254,693.36 | 239.82K |
Dec 31
| |||
Form 4
| +2.63% | 6.14K |
$2.23 | -$12,754.74 | 239.82K |
Dec 18 - Dec 19
| |||
Form 4
| +4.91% | 10.93K |
$2.31 | -$19,818.51 | 233.67K |
Dec 15 - Dec 17
| |||
Form 4
| -55.07% | -273.00K |
$3.41 | -$930,203.21 | 222.74K |
Jun 20 - Jun 23
| |||
Form 4
| -4.16% | -21.53K |
$5.03 | -$108,300.93 | 495.74K |
Apr 20
| |||
Form 4
| +16.96% | 75K |
$0.83 | $62,500.00 | 517.27K |
Dec 18
| |||
Form 4
| -8.87% | -43.06K |
$7.38 | -$317,797.56 | 442.27K |
Apr 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
$1.08 | $325,000.00 | 485.33K |
Dec 12
| |||
Form 4
| +106.23% | 250K |
—
|
—
| 485.33K |
Apr 20
| |||
Form 4
| -6.81% | -17.21K |
$4.86 | -$83,626.02 | 235.34K |
Mar 31
| |||
Form 4
| +283.36% | 186.67K |
—
|
—
| 252.54K |
Mar 31 - Dec 16
| |||
Form 4
| +784.60% | 58.43K |
—
|
—
| 65.88K |
May 27
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 31 - Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30 - Jul 8
| |||
Form 4
| +0.19% | 1.05K |
$100.00 | $105,000.00 | 557.45K |
Oct 3 - Oct 17
| |||
| No matching records found | |||||||||
BIOSANTE PHARMACEUTICALS INC (ANIP) Snapshot price: $60.51
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.76% | -5.40K |
$43.50 | -$234,759.99 | 190.31K |
Apr 6 - Apr 7
| |||
Form 4
| -3.40% | -6.88K |
$38.92 | -$267,885.50 | 195.71K |
Mar 28 - Mar 31
| |||
Form 4
| -12.90% | -30.00K |
$70.07 | -$2,102,177.15 | 202.59K |
May 13 - May 15
| |||
Form 4
| -0.72% | -1.69K |
$68.60 | -$116,071.20 | 232.59K |
Apr 16
| |||
Form 4
| -2.25% | -5.40K |
$70.50 | -$380,488.50 | 234.28K |
Apr 6 - Apr 7
| |||
Form 4
| -1.10% | -2.68K |
$70.54 | -$188,906.12 | 239.68K |
Mar 31
| |||
Form 4
| +18.18% | 37.28K |
—
|
—
| 242.36K |
Mar 28
| |||
Form 4
| -6.31% | -27.63K |
$63.52 | -$1,754,959.79 | 410.15K |
Mar 18 - Mar 19
| |||
Form 4
| -0.66% | -1.38K |
$61.88 | -$85,085.00 | 207.26K |
May 22
| |||
Form 4
| -0.77% | -1.61K |
$60.21 | -$96,998.31 | 208.63K |
Apr 16
| |||
Form 4
| +14.79% | 27.09K |
$57.06 | -$114,918.84 | 210.24K |
Apr 6 - Apr 7
| |||
Form 4
| -1.37% | -2.55K |
$58.22 | -$148,461.00 | 183.16K |
Mar 31
| |||
Form 4
| -11.56% | -24.28K |
$34.10 | -$2,373,144.47 | 185.71K |
Mar 12 - Mar 14
| |||
Form 4
|
—
|
0
|
$44.03 | -$825,407.33 | 209.98K |
Mar 1
| |||
Form 4
| -0.47% | -991.00 |
$47.01 | -$46,586.91 | 210.83K |
May 22
| |||
Form 4
| -0.55% | -1.16K |
$51.22 | -$59,466.42 | 211.82K |
Apr 17
| |||
Form 4
| -0.68% | -1.45K |
$51.24 | -$74,349.24 | 212.99K |
Apr 7
| |||
Form 4
| +11.80% | 22.63K |
—
|
—
| 214.44K |
Mar 7 - Mar 31
| |||
Form 4
| +8.93% | 15.72K |
$39.86 | -$1,830,489.27 | 191.81K |
Aug 22
| |||
Form 4
| -0.47% | -836.00 |
—
|
—
| 176.08K |
Aug 9
| |||
Form 4
| -0.56% | -991.00 |
$49.54 | -$49,094.14 | 176.92K |
May 22
| |||
Form 4
| -0.65% | -1.16K |
$43.25 | -$50,213.25 | 177.91K |
Apr 16
| |||
Form 4
| +11.70% | 18.75K |
—
|
—
| 179.07K |
Apr 7
| |||
Form 4
| +11.43% | 16.45K |
$6.36 | $104,596.56 | 160.32K |
Jan 8
| |||
Form 4
| -0.91% | -1.32K |
—
|
—
| 143.88K |
Dec 15
| |||
Form 4
| +1.75% | 2.5K |
$40.95 | $102,375.00 | 145.19K |
Nov 12
| |||
Form 4
| +7.54% | 10K |
$6.36 | $63,600.00 | 142.69K |
Aug 10
| |||
Form 4
| -1.09% | -1.47K |
$53.10 | -$78,003.90 | 132.69K |
May 22
| |||
Form 4
| +3.87% | 5K |
$6.36 | $31,800.00 | 134.16K |
May 7
| |||
Form 4
| +13.14% | 15K |
—
|
—
| 129.16K |
Apr 16
| |||
Form 4
| -39.65% | -75.00K |
$63.00 | -$4,725,000.00 | 114.16K |
Mar 12
| |||
Form 4
| +0.53% | 1K |
$26.50 | $26,500.00 | 189.16K |
Sep 9
| |||
Form 4
| +7.30% | 12.8K |
—
|
—
| 188.16K |
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| +3.85% | 6.5K |
$36.57 | -$206,297.58 | 175.37K |
Scheduled
|
Mar 5
| ||
Form 4
| +4.00% | 6.5K |
$32.86 | -$185,474.82 | 168.87K |
Scheduled
|
Feb 25
| ||
Form 4
| +4.17% | 6.5K |
$21.00 | -$118,521.18 | 162.38K |
Scheduled
|
Feb 12
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +4.35% | 6.5K |
$19.79 | -$111,700.97 | 155.88K |
Scheduled
|
Feb 5
| ||
Form 4
| +4.55% | 6.5K |
$21.34 | -$120,437.88 | 149.38K |
Scheduled
|
Jan 29
| ||
Form 4
| +4.76% | 6.5K |
$23.99 | -$135,396.17 | 142.89K |
Scheduled
|
Jan 22
| ||
Form 4
| +5.00% | 6.5K |
$23.11 | -$130,412.52 | 136.4K |
Scheduled
|
Jan 15
| ||
Form 4
| +5.26% | 6.5K |
$20.83 | -$117,536.30 | 129.9K |
Scheduled
|
Jan 8
| ||
Form 4
| +5.56% | 6.5K |
$19.41 | -$109,561.33 | 123.41K |
Scheduled
|
Jan 2
| ||
Form 4
| +5.88% | 6.5K |
$16.91 | -$95,439.48 | 116.91K |
Scheduled
|
Dec 26
| ||
Form 4
| +6.25% | 6.5K |
$15.13 | -$85,385.25 | 110.42K |
Scheduled
|
Dec 18
| ||
Form 4
| +6.67% | 6.5K |
$14.72 | -$83,074.60 | 103.92K |
Scheduled
|
Dec 11
| ||
Form 4
| +7.14% | 6.5K |
$13.01 | -$73,443.68 | 97.42K |
Scheduled
|
Dec 4
| ||
Form 4
| +7.69% | 6.5K |
$14.59 | -$82,356.68 | 90.93K |
Scheduled
|
Nov 27
| ||
Form 4
| +8.33% | 6.5K |
$13.42 | -$75,717.08 | 84.44K |
Scheduled
|
Nov 22
| ||
Form 4
| +9.09% | 6.5K |
$11.32 | -$63,886.69 | 77.94K |
Scheduled
|
Nov 13
| ||
Form 4
| +10.00% | 6.5K |
$11.10 | -$62,672.67 | 71.44K |
Scheduled
|
Nov 6
| ||
Form 4
| +11.11% | 6.5K |
$10.08 | -$56,873.46 | 64.95K |
Scheduled
|
Oct 30
| ||
Form 4
| +12.50% | 6.5K |
$11.45 | -$64,639.60 | 58.45K |
Scheduled
|
Oct 23
| ||
Form 4
| +14.29% | 6.5K |
$10.66 | -$60,167.86 | 51.96K |
Scheduled
|
Oct 16
| ||
Form 4
| +16.67% | 6.5K |
$9.95 | -$56,161.19 | 45.47K |
Scheduled
|
Oct 9
| ||
Form 4
| +20.00% | 6.5K |
$10.10 | -$56,984.08 | 38.97K |
Scheduled
|
Oct 2
| ||
Form 4
| +25.00% | 6.5K |
$9.09 | -$51,283.64 | 32.48K |
Scheduled
|
Sep 25
| ||
Form 4
| +33.33% | 6.5K |
$8.19 | -$46,216.46 | 25.98K |
Scheduled
|
Sep 18
| ||
Form 4
| +50.00% | 6.5K |
$6.97 | -$39,316.67 | 19.48K |
Scheduled
|
Sep 11
| ||
Form 4
| +100.00% | 6.5K |
$6.95 | -$39,234.27 | 12.99K |
Scheduled
|
Sep 4
| ||
Form 4
| -46.39% | -5.63K |
$7.07 | -$39,874.86 | 6.51K |
Scheduled
|
Aug 28
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Jun 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4
|
∞
| 1.97M |
—
|
—
| 1.97M |
Scheduled
|
Jun 19
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||